8-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95%, 250mg

2-(4-Methoxy-phenyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-ylamine, 95.0%, 100mg

3,3-DIFLUOROBICYCLO[3.1.0]HEXANE-6-CARBOXYLIC ACID, 95.0%, 250mg

Ethyl 3,4,5-trihydroxybenzoate, 97.0%, 500g

N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

N,N'-Bis(2-phenylethyl)ethanediamide, 95+%, 25g

2,3,5-Trichlorobenzaldehyde, 95.0%, 1g

methyl 2-amino-4-(2,4-dimethoxyphenyl)thiophene-3-carboxylate, 95.0%, 1g

1-tert-butyl 2-methyl (2S,3R)-3-amino-1,2-pyrrolidinedicarboxylate hydrochloride, 95.0%, 100mg

4-Ethyl-pentafluoroethylbenzene, 1g

Objetivo Plan semi apocromático PLM 100x/0,80 LWD IOS. Distancia de trabajo 2,1 mm. Sin corrección de cubreobjetos

5-Iodouridine, 99.0%, 10g

6-Hydroxy-L-tryptophan (TFA), 95%, 25mg